News

The SLM-310 is a groundbreaking LCOS-based spatial light modulator, engineered for high-power laser processing with advanced thermal management and precision.
Equillium, Inc. raises $50M to advance EQ504, a novel AhR modulator for ulcerative colitis. Phase 1 trials begin mid-2026. Click for more on EQ stock prospects.
Cavion presents data that its calcium channel modulator CX-8998 significantly suppresses seizures in GAERS and WAG/Rij rat models of absence epilepsy ...
Infectious diseases can have very different effects on different people; some individuals may have virtually no symptoms from COVID-19, for example, while others are killed by the viral disease.
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the most promising future stocks according to Wall Street analysts.
(Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the dosing of the first participants in its Phase 1 ...
Cleveland Clinic Abu Dhabi has become the first in the MENA region to use the Artisse Intrasaccular Flow Modulator, a ...